Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Cancer Home

National Aggregate

Five-Year Summary: January 2012 to December 2016

Tables and graphs report on cancer screening services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the October 2017 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.


Screening Totals by Year

Number of Women Screened by Year

Total women screened: 2012: 539,970, 2013: 513,233, 2014: 378,414, 2015: 333,757, and 2016: 315,401. Women receiving NBCCEDP-funded Pap tests: 2012: 251,740, 2013: 211,173, 2014: 148,189, 2015: 139,990, and 2016: 132,177. Women receiving NBCCEDP-funded mammograms: 2012: 343,713, 2013: 335,046, 2014: 245,766, 2015: 203,621, and 2016: 192,390.

This bar graph illustrates the number of women who received NBCCEDP-funded screenings by calendar year from January 2012 to December 2016.

Program Overview

Women Served through the NBCCEDP
Category Number
Women served [1] 1,517,200
Women screened [2] 1,453,979
Women receiving Pap tests 788,144
Women receiving mammography 938,869
Women receiving cervical cancer screening and diagnostic services 823,679
Women receiving breast cancer screening and diagnostic services 1,342,057

Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

1: Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure.

2: Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test).

Data source: October 2017 submission of NBCCEDP Minimum Data Elements (MDE).

Cervical Cancer Screening

Distribution of Women Receiving Pap Tests by Race/Ethnicity

White: 37.4%, Black: 13.3%, Asian/Pacific Islander: 6.4%, American Indian/Alaska Native: 4.6%, Multiracial: 0.6%, Hispanic: 36.5%, Unknown: 1.1%.

This pie chart illustrates the distribution of 788,144 women receiving an NBCCEDP-funded Pap test from January 2012 to December 2016 by race and ethnicity.

Distribution of Women Receiving Pap Tests by Age

Younger than 30: 5.7%, 30 to 39: 10.5%, 40 to 49: 35.3%, 50 to 64: 47.8%, 65 and older: 0.7%.

This pie chart illustrates the distribution of 788,144 women receiving an NBCCEDP-funded Pap test from January 2012 to December 2016 by age.

Cervical Results and Outcomes
Category Number
Pap tests provided 893,921
Pap tests with abnormal results [1] 30,310
Percentage of Pap tests with abnormal results 3.4
Age-adjusted percentage [2] 3.2
Cervical cancers or premalignant cervical lesions [3] 20,290
CIN1 or LSIL 12,501
CIN2 or worse [4] 7,789
Rate of CIN2 or worse detected per 1,000 Pap tests [4] 8.7
Age-adjusted rate per 1,000 Pap tests [2] 8.0

1: Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance – cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

2: Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

3: Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, carcinoma in situ (CIS), and invasive cervical cancer.

4: Includes HSIL, CIN2, CIN3, CIS, and invasive cervical cancer.

Table includes only NBCCEDP-funded Pap tests. An additional 15,974 women, not included above, were diagnosed with LSIL, HSIL, CIN1, CIN2, CIN3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test funded through another source.

Breast Cancer Screening

Distribution of Women Receiving Mammograms by Race/Ethnicity

White: 39.3%, Black: 17.7%, Asian/Pacific Islander: 6.3%, American Indian/Alaska Native: 3.5%, Multiracial: 0.5%, Hispanic: 31.4%, Unknown: 1.3%.

This pie chart illustrates the distribution of 938,869 women receiving an NBCCEDP-funded mammogram from January 2012 to December 2016 by race and ethnicity.

Distribution of Women Receiving Mammograms by Age

Younger than 40: 1.8%, 40 to 49: 17.4%, 50 to 64: 78.7%, 65 and older: 2.1%.

This pie chart illustrates the distribution of 938,869 women receiving an NBCCEDP-funded mammogram from January 2012 to December 2016 by age.

Breast Results and Outcomes
Category Number
Mammograms provided 1,323,196
Mammograms with abnormal results [1] 207,420
Percentage of mammograms with abnormal results 15.7
Age-adjusted percentage [2] 16.1
Breast cancers detected [3] 14,711
Rate of breast cancers detected per 1,000 mammograms 11.1
Age-adjusted rate per 1,000 mammograms [2] 11.3

1: Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required).

2: Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

3: Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. An additional 5,077 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram funded through another source.

Stay Informed

TOP